Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
The clinical effect on acne vulgaris of topical treatment with meclocycline sulfosalicylate and systemic treatment with peroral tetracycline (500 mg daily) was compared in a double-blind study of 60 patients treated for 8 weeks. The reducing effect of Meclosorb cream and tetracycline tablets on the number of closed comedones, pustules, papules and cysts was marked and not significantly different. The effect of Meclosorb on open comedones was weak and of slow onset. No side effects were registered. Topical treatment with Meclosorb is an effective and safe alternative to systemic tetracycline treatment of acne vulgaris.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010118:Oxytetracycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011897:Random Allocation; D013752:Tetracycline / Q000627:therapeutic use
C100122:meclocycline; D013752:Tetracycline; D010118:Oxytetracycline